Tezepelumab (TSLP) - Research Grade Biosimilar
Product Specifications
Background
Tezepelumab is under investigation in clinical trial NCT03406078 (Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma) .
Immunogen
Homo sapiens / TSLP [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG2-lambda
NCBI Organism
Homo sapiens
Other Product Names
AMG 157, AMG-157, MEDI-9929, MEDI9929, anti-TSLP-Receptor (TSLP-R; Crl2)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-P458665-5MG 5 mg
(3aR,4R,6R,7aS)-Pinanediol Ester Pyrrolidinyl Propan-1-one
Sign In for Pricing
View Details 
